Characteristics of Efficacy Evidence Supporting Approval of Supplemental Indications for Prescription Drugs in United States, 2005-14: Systematic Review March 15, 2026
Reductions in Use of Colchicine After FDA Enforcement of Market Exclusivity in a Commercially Insured Population March 15, 2026
Medical Schools’ Industry Interaction Policies Not Associated with Trainees’ Self-Reported Behavior as Residents: Results of a National Survey March 15, 2026
Innovative Research Methods for Studying Treatments for Rare Diseases: Methodological Review March 15, 2026
Do March‐in Rights Ensure Access to Medical Products Arising From Federally Funded Research? A Qualitative Study March 15, 2026
FDA Designations for Therapeutics and Their Impact on Drug Development and Regulatory Review Outcomes March 15, 2026
The Roles of Academia, Rare Diseases, and Repurposing in the Development of the Most Transformative Drugs March 15, 2026
Vaccine Pipeline Has Grown During the Past Two Decades with More Early-Stage Trials From Small and Medium-Size Companies March 15, 2026